References
- 1Echeverria LE, Morillo CA. American Trypanosomiasis (Chagas Disease). Infect Dis Clin North Am. 2019; 33(1): 119–34. DOI: 10.1016/j.idc.2018.10.015
- 2Lidani KCF, Andrade FA, Bavia L, et al. Chagas Disease: From Discovery to a Worldwide Health Problem. Front Public Health. 2019; 7: 166. DOI: 10.3389/fpubh.2019.00166
- 3Nunes MCP, Beaton A, Acquatella H, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation. 2018; 138(12): e169–e209. DOI: 10.1161/CIR.0000000000000599
- 4Abel LC, Rizzo LV, Ianni B, et al. Chronic Chagas’ disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun. 2001; 17(1): 99–107. DOI: 10.1006/jaut.2001.0523
- 5De Bona E, Lidani KCF, Bavia L, et al. Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy? Front Immunol. 2018; 9: 1842. DOI: 10.3389/fimmu.2018.01842
- 6Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009; 49(5): e52–54. DOI: 10.1086/605091
- 7Shen L, Ramires F, Martinez F, et al. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy. Circ Heart Fail. 2017; 10(11):
e004361 . DOI: 10.1161/CIRCHEARTFAILURE.117.004361 - 8Abuhab A, Trindade E, Aulicino GB, Fujii S, Bocchi EA, Bacal F. Chagas’ cardiomyopathy: The economic burden of an expensive and neglected disease. International Journal of Cardiology. 2013; 168(3): 2375–80. DOI: 10.1016/j.ijcard.2013.01.262
- 9Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ. Estimating the Burden of Chagas Disease in the United States. PLoS Negl Trop Dis. 2016; 10(11):
e0005033 . DOI: 10.1371/journal.pntd.0005033 - 10Lee BY, Bacon KM, Bottazzi ME, Hotez PJ. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis. 2013; 13(4): 342–8. DOI: 10.1016/S1473-3099(13)70002-1
- 11Coura JR. Chagas disease: control, elimination and eradication. Is it possible? Mem Inst Oswaldo Cruz. 2013; 108(8): 962–7. DOI: 10.1590/0074-0276130565
- 12Massad E. The elimination of Chagas’ disease from Brazil. Epidemiol Infect. 2008; 136(9): 1153–64. DOI: 10.1017/S0950268807009879
- 13Carmona-Castro O, Moo-Llanes DA, Ramsey JM. Impact of climate change on vector transmission of Trypanosoma cruzi (Chagas, 1909) in North America. Med Vet Entomol. 2018; 32(1): 84–101. DOI: 10.1111/mve.12269
- 14Garrido R, Bacigalupo A, Peña-Gómez F, et al. Potential impact of climate change on the geographical distribution of two wild vectors of Chagas disease in Chile: Mepraia spinolai and Mepraia gajardoi. Parasit Vectors. 2019; 12(1): 478. DOI: 10.1186/s13071-019-3744-9
- 15Medone P, Ceccarelli S, Parham PE, Figuera A, Rabinovich JE. The impact of climate change on the geographical distribution of two vectors of Chagas disease: implications for the force of infection. Philos Trans R Soc Lond B Biol Sci. 2015; 370(1665):
20130560 . DOI: 10.1098/rstb.2013.0560 - 16Tamayo LD, Guhl F, Vallejo GA, Ramírez JD. The effect of temperature increase on the development of Rhodnius prolixus and the course of Trypanosoma cruzi metacyclogenesis. PLoS Negl Trop Dis. 2018; 12(8):
e0006735 . DOI: 10.1371/journal.pntd.0006735 - 17Ayala S, Alvarado S, Cáceres D, Zulantay I, Canals M. Effects of climate change on reproductive number of Chagas disease. Rev Med Chil. 2019; 147(6): 683–92. DOI: 10.4067/S0034-98872019000600683
- 18Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Tropica. 2010; 115(1–2): 22–7. DOI: 10.1016/j.actatropica.2009.07.019
- 19Navarro M, Navaza B, Guionnet A, López-Vélez R. Chagas Disease in Spain: Need for Further Public Health Measures. PLoS Negl Trop Dis. 2012; 6(12):
e1962 . DOI: 10.1371/journal.pntd.0001962 - 20Requena-Méndez A, Aldasoro E, de Lazzari E, et al. Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2015; 9(2):
e0003540 . DOI: 10.1371/journal.pntd.0003540 - 21Organización Panamericana De La Salud. Estimación cuantitativa de la enfermedad de Chagas en las Americas. Organización Panamericana de la Salud, Montevideo, Uruguay; 2006.
- 22World Health Organization. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. World Health Organization Weekly Epidemiological Record. 2015; 90(6): 33–44.
- 23Arnal A, Waleckx E, Rico-Chávez O, Herrera C, Dumonteil E. Estimating the current burden of Chagas disease in Mexico: A systematic review and meta-analysis of epidemiological surveys from 2006 to 2017. PLoS Negl Trop Dis. 2019; 13(4):
e0006859 . DOI: 10.1371/journal.pntd.0006859 - 24Martins-Melo FR, Ramos AN, Alencar CH, Heukelbach J. Prevalence of Chagas disease in Brazil: a systematic review and meta-analysis. Acta Trop. 2014; 130: 167–74. DOI: 10.1016/j.actatropica.2013.10.002
- 25Olivera MJ, Fory JA, Porras JF, Buitrago G. Prevalence of Chagas disease in Colombia: A systematic review and meta-analysis. PLoS One. 2019; 14(1):
e0210156 . DOI: 10.1371/journal.pone.0210156 - 26Ibáñez-Cervantes G, León-García G, Castro-Escarpulli G, et al. Evolution of incidence and geographical distribution of Chagas disease in Mexico during a decade (2007–2016). Epidemiol Infect. 2018; 147:
e41 . DOI: 10.1017/S0950268818002984 - 27Gunter SM, Ronca SE, Sandoval M, et al. Chagas Disease Infection Prevalence and Vector Exposure in a High-Risk Population of Texas Hunters. Am J Trop Med Hyg. 2020; 102(2): 294–7. DOI: 10.4269/ajtmh.19-0310
- 28Nunes MCP, Buss LF, Silva JLP, et al. Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of Trypanosoma cruzi–Seropositive Individuals. Circulation. 2021; 144(19): 1553–66. DOI: 10.1161/CIRCULATIONAHA.121.055112
- 29Rassi A, Rassi A, Little WC, et al. Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med. 2006; 355(8): 799–808. DOI: 10.1056/NEJMoa053241
- 30Assunção AN, Jerosch-Herold M, Melo RL, et al. Chagas’ heart disease: gender differences in myocardial damage assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2016; 18: 88. DOI: 10.1186/s12968-016-0307-5
- 31Novak JR, Peak T, Gast J, Arnell M. Associations Between Masculine Norms and Health-Care Utilization in Highly Religious, Heterosexual Men. Am J Mens Health. 2019; 13(3). DOI: 10.1177/1557988319856739
- 32Juel K, Christensen K. Are men seeking medical advice too late? Contacts to general practitioners and hospital admissions in Denmark 2005. J Public Health (Oxf). 2008 March; 30(1): 111–3. DOI: 10.1093/pubmed/fdm072
- 33Kapur N, Hunt I, Lunt M, McBeth J, Creed F, Macfarlane G. Primary care consultation predictors in men and women: a cohort study. Br J Gen Pract. 2005; 55(511): 108–13.
- 34Lima-Costa MF, Peixoto SV, Ribeiro ALP. Chagas disease and mortality in old age as an emerging issue: 10 year follow-up of the Bambuí population-based cohort study (Brazil). International Journal of Cardiology. 2010; 145(2): 362–3. DOI: 10.1016/j.ijcard.2010.02.036
- 35Martins-Melo FR, Carneiro M, Ribeiro ALP, Bezerra JMT, Werneck GL. Burden of Chagas disease in Brazil, 1990–2016: findings from the Global Burden of Disease Study 2016. Int J Parasitol. 2019; 49(3–4): 301–10. DOI: 10.1016/j.ijpara.2018.11.008
- 36Martins-Melo FR, Carneiro M, Ramos AN, Heukelbach J, Ribeiro ALP, Werneck GL. The burden of Neglected Tropical Diseases in Brazil, 1990–2016: A subnational analysis from the Global Burden of Disease Study 2016. PLoS Negl Trop Dis. 2018; 12(6):
e0006559 . DOI: 10.1371/journal.pntd.0006559